If you’ve been following the saga of drug shortages in this publication, you know how America’s cancer institutions are scrambling to obtain platinum-based drugs for their patients.
Paul Marks To Retire As President, CEO Of Memorial Sloan-Kettering Cancer Center
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
YOU MAY BE INTERESTED IN
Nearly 80% of NIH staff will be furloughed if Congress fails to fund the federal government or pass a continuing resolution before midnight Saturday, Sept. 30—halting many administrative functions and nonclinical activities in the agency’s research pipelines.
OK, name a movie doctor—fast!Chances are, you are thinking of Robin Williams as Patch Adams in the eponymous flick or of Harrison Ford as Dr. Richard Kimble in “The Fugitive.”
Many readers of The Cancer Letter will have seen or at least be aware of the buzz surrounding release of the new “Oppenheimer” movie, which has received excellent reviews.
NCI’s Surveillance, Epidemiology, and End Results Program in the Division of Cancer Control and Population Sciences at NCI is marking 50 years of cancer surveillance.
The Advanced Research Projects Agency for Health has established ARPANET-H, a nationwide health innovation network anchored by three ARPA-H regional hubs.
